Dynamic Hot Spring Hydrotherapy for Gait Disorders and Balance Function Recovery After Stroke

Обзор

Our research aims to analyze and compare the improvement of various indicators of gait disorders and balance function before and after dynamic hot spring hydrotherapy and conventional exercise intervention, and clarify the therapeutic effect of dynamic hot spring hydrotherapy on gait disorders and balance function in stroke patients.

Вмешательства

• Другое Dynamic hot spring hydrotherapy intervention
  Under closed management, patients will receive 5 times a week, 20 minutes of routine rehabilitation and 20 minutes of hot spring water exercise each time: (1) 20 minutes of routine rehabilitation: including routine muscle strength enhancement training, joint range of motion training, and neuropathological methods (Bobath method, proprioceptive neuromuscular facilitation technique, etc.); (2) 20 minute hot spring water balance walking function training
• Другое Conventional rehabilitation intervention
  Under closed management, patients will receive routine physical therapy for 40 minutes 5 times a week: 1) 20 minutes of routine rehabilitation, including routine muscle strength enhancement training, joint range of motion training, and neuropathological methods (Bobath method, proprioceptive neuromuscular facilitation technique, etc.); 2) 20 minute land balance walking function training

Первичные конечные точки

• Timed Up and Go Test, (TUG) [Срок оценки: From enrollment to the end of treatment at 2 weeks.]
• 10 Meter Walk Test, (10WMT) [Срок оценки: From enrollment to the end of treatment at 2 weeks.]
• Berg Balance Scale, BBS [Срок оценки: From enrollment to the end of treatment at 2 weeks.]
• Fugl-Meyer Balance Assessment,（FMA-B) [Срок оценки: From enrollment to the end of treatment at 2 weeks.]
• Forced Vital Capacity, (FVC). [Срок оценки: From enrollment to the end of treatment at 2 weeks.]
• FEV1 [Срок оценки: From enrollment to the end of treatment at 2 weeks.]
• Maximum Voluntary Ventilation, (MVV) [Срок оценки: From enrollment to the end of treatment at 2 weeks.]
• VO2 [Срок оценки: From enrollment to the end of treatment at 2 weeks.]
• oxygen consumption per kg body weight, (VO2/Kg) [Срок оценки: From enrollment to the end of treatment at 2 weeks.]
• METS [Срок оценки: From enrollment to the end of treatment at 2 weeks.]

Вторичные конечные точки (4)

• anxiety [Срок оценки: From enrollment to the end of treatment at 2 weeks]
• sleep quality [Срок оценки: From enrollment to the end of treatment at 2 weeks]
• Self efficacy [Срок оценки: From enrollment to the end of treatment at 2 weeks]
• Neurotransmitters and Cytokines [Срок оценки: From enrollment to the end of treatment at 2 weeks]

Критерии участия

Критерии включения

• Patients with cerebral infarction or cerebral hemorrhage who meet the diagnostic criteria for stroke of the Chinese Medical Association; (2) Initial stroke<6 months, or last stroke event>6 months; (3) Age>=18 years old,<85 years old (increased risk of VCI over 85 years old); (4) NIHSS>4, NIHSS<26 points; (5) MRS score>=2 points; (6) complete CT or MRI; (7) No serious neurological or mental illness; Unconscious disorders, able to cooperate with relevant treatments; No severe cognitive impairment (MMSE>=15 points); (8) Berg Balance Scale>40 points; (9) The patient or family member signs an informed consent form.

Критерии исключения

• (1) Concurrent major diseases, such as heart, lung, liver, kidney and other organ diseases or failure; (2) There are contraindications for hydrotherapy such as acute infectious diseases, open skin wounds, and severe epilepsy; (3) There are other clinical issues that may affect the assessment results, such as low vision, fractures, vestibular diseases, etc; (4) There are other neurological disorders, such as multiple sclerosis, Parkinson's disease, etc; (5) Serious mental and psychological problems exist; (6) Malignant tumor patients; (7) Early pregnancy or high-risk pregnancy; (8) Serious alcohol abusers; (9) Patients with active bleeding, such as gastrointestinal bleeding, nosebleeds, and excessive menstruation.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение

Рандомизированное

Модель

Параллельные группы

Маскирование

Простое слепое

Основная цель

Лечение

Центры проведения

Китай · 1 центр

• Electroencephalography — Куньмин

Идентификаторы

NCT: NCT06955182 · Shen-PJ-Ke-2025-19

Первоисточники (государственные реестры)

• ClinicalTrials.gov (NIH, США)

Открыть это исследование на ClinicalTrials.gov ↗